Loren Pickart, the biochemist who first isolated GHK in the 1970s, described it as a "biological signal of tissue damage" that recruits repair cells and remodels the extracellular matrix
benefit: FDA only looked at risk, ignored benefits Off-label use: Doctors prescribe drugs off-label all the time Patient access: People are suffering and need options Regulatory capture: Big Pharma doesn't want cheap peptides competing The problem with these arguments: It's NOT off-label use Off-label only applies to FDA-approved drugs
Benefits BPC-157 Arginate preclinical research profile
Collagen production declines about 1% per year from the mid-20s onward
Specific to BPC-157 and TB-500, we just dont have the kind of high-quality human evidence that would allow me to directly or confidently recommend a specific product or a dose, or a route, or a treatment protocol for an orthopedic injury, and I tell them to be cautious. Splitter says he cautions his patients to be careful about peptides theyre getting online or from compounding pharmacies because they really dont know what theyre putting in their bodies
Brains were extracted and postfixed in 4% paraformaldehyde overnight, then transferred to 30% sucrose (Fisher Scientific) solution for cryoprotection and remained in the solution until sectioning
